These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11073152)

  • 41. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.
    Cerqueira DF; Portela MB; Pomarico L; de Araújo Soares RM; de Souza IP; Castro GF
    J Oral Pathol Med; 2010 Feb; 39(2):188-94. PubMed ID: 20040023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Oral candidal carriage and biotyping of Candida species in HIV positive patients].
    Deng HJ; Tao RC; Huang GW; Guo SZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jul; 42(7):428-9. PubMed ID: 17961365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular typing of candida albicans isolated from oral lesions of HIV-infected individuals.
    Powderly WG; Robinson K; Keath EJ
    AIDS; 1992 Jan; 6(1):81-4. PubMed ID: 1543569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential recovery of Candida species from subgingival sites in human immunodeficiency virus-positive and healthy children from Rio de Janeiro, Brazil.
    Portela MB; Souza IP; Costa EM; Hagler AN; Soares RM; Santos AL
    J Clin Microbiol; 2004 Dec; 42(12):5925-7. PubMed ID: 15583343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors affecting the adherence of Candida albicans to human buccal epithelial cells in human immunodeficiency virus infection.
    Tsang CS; Samaranayake LP
    Br J Dermatol; 1999 Nov; 141(5):852-8. PubMed ID: 10583166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection and pathogenicity of Candida albicans in HIV infection.
    Sweet SP
    Oral Dis; 1997 May; 3 Suppl 1():S88-95. PubMed ID: 9456665
    [No Abstract]   [Full Text] [Related]  

  • 47. Oral microflora and their relation to risk factors in HIV+ patients with oropharyngeal candidiasis.
    Sharifzadeh A; Khosravi AR; Shokri H; Asadi Jamnani F; Hajiabdolbaghi M; Ashrafi Tamami I
    J Mycol Med; 2013 Jun; 23(2):105-12. PubMed ID: 23721997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.
    Martins MD; Lozano-Chiu M; Rex JH
    Clin Infect Dis; 1998 Nov; 27(5):1291-4. PubMed ID: 9827284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased expression of virulence attributes in oral Candida albicans isolates from human immunodeficiency virus-positive individuals.
    Mane A; Gaikwad S; Bembalkar S; Risbud A
    J Med Microbiol; 2012 Feb; 61(Pt 2):285-290. PubMed ID: 21959206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.
    Brawner DL; Cutler JE
    J Clin Microbiol; 1989 Jun; 27(6):1335-41. PubMed ID: 2666442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of Candida dubliniensis in Venezuela.
    Hartung de Capriles C; Mata-Essayag S; Pérez C; Colella MT; Roselló A; Olaizola C; Abate SM
    Mycopathologia; 2005 Oct; 160(3):227-34. PubMed ID: 16205971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antifungal effect of mouth rinses on oral Candida counts and salivary flow in treatment-naïve HIV-infected patients.
    Patel M; Shackleton JA; Coogan MM; Galpin J
    AIDS Patient Care STDS; 2008 Aug; 22(8):613-8. PubMed ID: 18627277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.
    Chattopadhyay A; Gray LR; Patton LL; Caplan DJ; Slade GD; Tien HC; Shugars DC
    Infect Immun; 2004 Apr; 72(4):1956-63. PubMed ID: 15039315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of internal transcribed spacer region of ribosomal DNA sequence analysis for molecular characterization of Candida albicans and Candida dubliniensis isolates from HIV-infected patients.
    Millon L; Piarroux R; Drobacheff C; Monod M; Grenouillet F; Bulle B; Bole J; Blancard A; Meillet D
    Med Mycol; 2002 Dec; 40(6):535-43. PubMed ID: 12521117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral candidiasis in HIV-infected patients and its relation to CD4 + counts: an adjunct clinical marker of HIV disease progression.
    Gupta E; Vajpayee M; Xess I; Seth P
    Trop Doct; 2006 Apr; 36(2):127. PubMed ID: 16611459
    [No Abstract]   [Full Text] [Related]  

  • 56. Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.
    Diaz-Guerra TM; Martinez-Suarez JV; Laguna F; Valencia E; Rodriguez-Tudela JL
    AIDS; 1998 Sep; 12(13):1601-10. PubMed ID: 9764778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
    Martins MD; Lozano-Chiu M; Rex JH
    Clin Infect Dis; 1997 Oct; 25(4):843-6. PubMed ID: 9356799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Candida albicans: the relationship between morphotypes and in-vitro adhesivity to the oral mucosa cells of HIV-positive and AIDS patients. I].
    Malighetti V; Arosio M; Bellotti MG; Spadari E; Zambellini Artini M; Spadari F; Riviera L
    Minerva Stomatol; 1998 Sep; 47(9):351-9. PubMed ID: 9835741
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral candidiasis in HIV+ patients under treatment with protease inhibitors.
    Witzel AL; Silveira FR; Pires Mde F; Lotufo MA
    Braz Oral Res; 2008; 22(4):371-7. PubMed ID: 19148395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Asymptomatic oral carriage of Candida species in HIV-infected patients in the highly active antiretroviral therapy era.
    Costa CR; Cohen AJ; Fernandes OF; Miranda KC; Passos XS; Souza LK; do Rosário Rodrigues Silva M
    Rev Inst Med Trop Sao Paulo; 2006; 48(5):257-61. PubMed ID: 17086312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.